doi: 10.1089/acm.2006.12.881
The measures differ across rows, including hippocampal volume, dementia risk, clinical decline, and an aging clock, so the bars are not strictly comparable, and a larger bar reflects a larger measured effect rather than stronger evidence
This suggests that GHK-Cu and related peptides could be investigated as potential non-addictive research alternatives in the context of pain management, alongside opiate medications and NSAIDs, which are known for their potential side effects, including negative impacts on cardiovascular health
You start looking for alternatives
Individuals with insulin resistance, type 2 diabetes, or previous weight loss plateaus may also benefit
We mapped the distribution of these three populations in the rat spatial data, and our previous mouse DVC atlas 12 (Fig